← Open Payments lookup

ADEBOLA AJANAKU: Open Payments

NPI 1669927224 · UNION, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$833 in 44 payments from 11 companies in 2025. Trend: 2023 $762 · 2024 $820 · 2025 $833

Food & beverage: $833
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.8$249
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)7$117
Janssen Pharmaceuticals, Inc5$83
Teva Pharmaceuticals USA, Inc.5$74
Otsuka America Pharmaceutical, Inc.4$66
Alkermes, Inc.3$54
E.R. Squibb & Sons, L.L.C.3$50
ABBVIE INC.3$47
Supernus Pharmaceuticals, Inc.3$42
Vanda Pharmaceuticals Inc.2$33

Products named: INGREZZA, CAPLYTA, INVEGA SUSTENNA, UZEDY, ARISTADA, COBENFY, REXULTI, VRAYLAR.

Industry payments across NJ — which companies pay providers there.